-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Secondary sclerosing cholangitis (SSC) is a progressive disease characterized by chronic inflammation of the bile ducts and obstruction of the biliary tract
To this end, the researchers included data on all SSC patients between 1996 and 2021, a total of 80 patients with confirmed SSC, followed up until May 2021, with a median follow-up period of 9 months after the first diagnosis, of which liver biopsies of 30 patients confirmed characteristic histopathological changes
The results of the study showed that 80 patients with
This study confirmed that secondary sclerosing cholangitis is a progressive disease with a poor long-term prognosis
Original Source:
Chengcheng Christine Zhan.